Molecules for indicating toxicity producing capacity of aflatoxin producing bacteria and application thereof
An aflatoxin and virulence technology, applied in analytical materials, biological material analysis, material testing products, etc., can solve problems such as difficulty in meeting advance warning and guidance for prevention and control, lack of molecular early warning research examples, and difficulty in meeting, and achieve practical The effect of strong performance, easy operation, and easy promotion and application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0051] Example 1 Preparation of Molecular AFT-YJFZP008 of Yellowlaminin Catinumi
[0052] In accordance with the following formula, the recipe medium: 3% (w / v) sucrose, 0.3% (w / v) naNO3, 0.1% (w / v) K2HPO4, 0.05% (w / v) MgSO4 · 7H2O, 0.05% ( W / V) KCl, 0.001% (W / V) FESO4, pH 6.5, and configured to obtain a Castes medium. Random selection of public literature "China's typical flower production area of Huang Shujin distribution, China" Henzy-2, Hubha-24, JXZS-29-2, LNCT-6, GXFC-34, GDZJ-122-2, JSNT-1, HUNDX-7, HBHA-8-17, etc., each inoculated to the above In the culture medium, after 5 days of 200 rpm / min, it is conventional method to sufficiently homogenate, crushing the cells, and purified by a routine protein purification system, protein electrophoresis, immune affinity, etc. Macrostatic Molecular AFT-YJFZP008. The test results show that AFT-YJFZP008 can be prepared in the above-mentioned drug strain culture, and HBHA-8-17 is prepared in the same culture conditions, ...
Embodiment 2
[0071] Example 2 Nano-antibody prepared by indicating a molecular AFT-YJFZP008 of a virulence of a yellow belantrimeric
[0072] The AFT-YJFZP008 is used as an immune antigen, and it can be developed using a conventional manner to immunize alpacal or BALB / C rats.
[0073] The prepared AFT-YJFZP008 described above is dissolved in conventional PBS buffer or physiological saline to a concentration of not less than 0.1 mg / ml, and then a complete adjuvant of Frego complete adjuvant, and through the back subcutaneous or intraced multi-point injection method. Immune alpaca, then enhance immunization once every 2-4 weeks, enhance immunization, with Freud's incomplete adjuvant to replace Ford's complete adjuvant. Using conventional ELISA processes to monitor the immune effect, after the oil blood, the oil is no longer rising, then the intravenous blood of the immune alpaca, the total RNA, the synthesis of cDNA, the VHH gene, the recovery of the VHH gene fragment, VHH gene Connect to bi...
Embodiment 3
[0075]Preparation Example 3 indicates aflatoxin producing virulent toxigenic molecules AFT-YJFZP008 embodiment a monoclonal antibody
[0076] The AFT-YJFZP008 is used as an immune antigen, and it can be developed using a conventional manner to immunize alpacal or BALB / C rats.
[0077] The AFT-YJFZP008 prepared above was dissolved in a conventional saline or PBS buffer to a concentration of not less than 0.1mg / mL, then an equal volume of Freund's complete adjuvant and emulsified by mixing, or by subcutaneous injection at multiple sites intradermally manner BALB / c mice, 2-4 weeks after booster immunization every 1, was replaced with Freund's incomplete adjuvant boosted when Freund's complete adjuvant. A conventional ELISA process monitoring immune effect, to BALB / c mice titer does not rise, the subsequent separation of immunized mouse splenocytes, spleen cells with murine myeloma cells SP2 / 0 fusion, semi-solid medium in which hybridoma cells completion of the cultivation m...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com